CognitMarket market news, portfolio research, and investor insights

Your market command center

Research the market. Understand your portfolio. Act with confidence.

Turn market-moving news into a focused daily view of the companies, portfolios, and ideas you care about.

Login
Create my free account
Free to start · No card required

Top Stories

The developments most likely to shape today’s market conversation.
Salesforce to buy Braze for $5.7 billion, CRM shares slide 3%
Company News

Salesforce to buy Braze for $5.7 billion, CRM shares slide 3%

STREETINSIDER.COM

Investing.com -- Salesforce (NYSE: CRM) agreed to acquire customer engagement software company Braze (NASDAQ: BRZE) for approximately $5.66 billion in enterprise value, offering $47.50 per share in cash in a deal aimed at strengthening its marketing and artificial intelligence capabilities.

Salesforce shares fell 3% following the announcement. Braze shares were halted pending news, with the stock expected to open higher after closing at $30.04 in the previous session. The proposed cash consideration represents a premium of approximately 58% to that closing price.

The deal would add Braze’s real-time customer engagement and AI-powered personalization technology to Salesforce’s marketing and customer relationship management products. The transaction is expected to close in Salesforce’s fiscal 2028, subject to shareholder approval and regulatory clearances.

“Bringing that capability together with Salesforce Marketing Cloud, CRM, and Data 360 will deliver that wow moment in every custom

Why is RTX stock rallying today?
Company News

Why is RTX stock rallying today?

INVESTING.COM

Investing.com -- RTX stock rallied 2.0% in pre-open trading after the Pratt & Whitney and Raytheon parent reported third-quarter 2026 results that comfortably beat analyst forecasts on both the top and bottom lines, and simultaneously raised its full-year financial targets.

Adjusted earnings per share came in at $2.26, a $0.48 beat versus the $1.78 consensus estimate, while quarterly revenue of $25.0 billion topped the $24.09 billion estimate and represented 11% growth from the prior-year period.

The raised guidance was arguably the more powerful catalyst. RTX lifted its full-year 2026 adjusted EPS outlook to a range of $7.65–$7.75, up from the prior forecast of $7.10–$7.25, with the midpoint of $7.70 clearing the analyst consensus of $7.25 by a meaningful margin.

The company also reported a record backlog of $340 billion, underpinned by more than $81 billion in new commercial and defense awards, signaling durable revenue visibility.

CEO Chris Calio noted that strong execution enab

‘Cannot play hide and seek’: Minister’s warning over haze sends Singapore agricultural stocks lower
Company News

‘Cannot play hide and seek’: Minister’s warning over haze sends Singapore agricultural stocks lower

CNBC.COM

Shares of several Singapore-listed agricultural companies fell Tuesday after Senior Minister K Shanmugam warned they won’t “escape responsibility” for their possible role in the haze blanketing the city-state.

“Companies cannot play hide and seek” with different corporate structures, hoping that will help them, Shanmugam said, revealing that seven companies had been questioned by the Singapore Exchange.

Bumitama Agri fell as much as 6.5%, while First Resources dropped to a low of 4.83%. Golden Agri Resources and Wilmar International slipped almost 2%.

Shanmugam, who is also home affairs minister for the city-state, said that some of the fires or smoke source points seem to be associated with First Resources, Bumitama Agri, as well as non-listed First Borneo Plantations.

“Take, for example, First Resources. It issued a detailed statement on its zero burning policy and firefighting efforts ... but statements, no matter how well drafted, are not good enough. Show us the evidence.”

Th

Cramer’s lightning round: ‘Do not own’ MFA Financial
Analyst & Opinion

Cramer’s lightning round: ‘Do not own’ MFA Financial

CNBC.COM

In this article

AppLovin: “It’s come down a lot, but in the end AppLovin is in the crosshairs of Alphabet and I don’t want to be there. ... I’m just going to have to say no.”

Vale S.A.: “I like it. I think that’s a good idea. Nice hedge against inflation too.”

MFA Financial: “These residential mortgage-backed stocks have just been absolutely horrendous, and I’m going to just say unequivocally: do not own that stock. I don’t care how low the price to earnings multiple is.”

Kratos Defense & Security Solutions: “People hate the defense stocks. I don’t want to touch the defense stocks.”

Twilio: “I think it’s valued correctly. That’s the problem. Therefore, I don’t see any upside or downside that I can pin anything on.”

Compass Pathways: “You’re up against J&J [Johnson & Johnson]. I will not go up against J&J. They’re too big and too powerful. I want to stay away from that one. You can spec, a small position, spec that they get approval, but it’s very, very difficult.”

Cintas: “We wa

Myriad Genetics stock surges on $210M prenatal unit sale
Company News

Myriad Genetics stock surges on $210M prenatal unit sale

STREETINSIDER.COM

Investing.com -- Myriad Genetics Inc (NASDAQ: MYGN) shares jumped 36% Tuesday following the company's announcement that it will sell its Prenatal Health testing business to Labcorp Holdings Inc (NYSE: LH) for $210 million in cash, plus inventory value at closing.

The transaction includes Myriad's Prequel, Foresight, SneakPeek, and FirstGene tests. The prenatal testing portfolio generated approximately $160 million in revenue over the last twelve months and served over 600,000 patients.

Sam Raha, President and CEO of Myriad Genetics, said the transaction is expected to be accretive to the company's revenue growth and profitability while strengthening the balance sheet to support investment in strategic priorities tied to the cancer care continuum.

Labcorp expects the acquisition to add approximately $160 million in revenue in year one and to be slightly accretive to adjusted earnings in the first year. The company anticipates reaching average diagnostics segment margins by the end of

BlackRock, GIC among investors chasing Indian telecom major Jio’s IPO as anchor bids top $26 billion
Company News

BlackRock, GIC among investors chasing Indian telecom major Jio’s IPO as anchor bids top $26 billion

CNBC.COM

India’s Jio Platforms has seen the anchor investor quota for its initial public offering oversubscribed more than 30 times, according to a source familiar with the matter, drawing bids from top asset managers including BlackRock, Capital Group and GIC.

The country’s largest telecommunications and digital services company, backed by Meta and Google, plans to raise up to 302 billion rupees ($3.2 billion) through India’s largest ever IPO in rupee terms.

According to the source, who is not allowed to speak on the matter due to legal restrictions, the company’s anchor book received total bids worth 2.5 trillion rupees ($26.3 billion) for the 81.1 billion rupee anchor book portion.

Jio Platforms, in a release on Monday, said it had finalized the allocation of 72.47 million equity shares to anchor investors at 1,119 rupees a share, at the upper range of the price band.

The anchor book is a portion of the total fundraise set aside for large institutional investors before the IPO opens for

1 / 6

For You

Personalize this briefing around the investments you care about.

Follow the market through your own lens.

Create a free account to bring watchlist updates, portfolios, and Autopilot status into this briefing.

Trending now

Top portfolios

From the Community

Recent questions, research, and investing ideas from members.

Data center and AI infrastructure stocks are facing renewed pressure after South Korean cloud company Elice's IPO plunged 30% on its market debut. This event amplifies growing investor concerns about overcapacity and debt within the AI-dedicated computing power sector .

Key points:

  • Elice's IPO, though small ($150M), is seen as a signal of bearish sentiment towards the AI build-out .
  • HSBC reiterated a 'reduce' rating on CoreWeave, citing 'debt market woes and moderating LLM revenues' .
  • Recent revenue disappointments from private AI algorithm companies like Anthropic and OpenAI are contributing to profitability concerns for neoclouds .
Data center stocks remain under pressure after Korea IPO plunges 30%

Data center stocks remain under pressure after Korea IPO plunges 30%

CNBC.COMOct 20, 3:45 PM UTC
0

Data center stocks, particularly 'neoclouds' like CoreWeave, are facing renewed pressure after a South Korean AI cloud company's IPO plunged 30% . This event signals growing investor wariness over potential overcapacity and debt market woes in the AI infrastructure sector . HSBC reiterated a 'reduce' rating on CoreWeave, citing structural concerns and moderating LLM revenues . This follows recent disappointments from private AI algorithm companies like Anthropic and OpenAI, which reported decelerating revenues . The broader market saw the AI 100 basket fall 5% last week, with CoreWeave's credit default swaps surging . This trend highlights increasing scrutiny on the profitability and financial health of companies in the AI value chain.

Data center stocks remain under pressure after Korea IPO plunges 30%

Data center stocks remain under pressure after Korea IPO plunges 30%

CNBC.COMOct 20, 3:45 PM UTC
Global equities: Rally or selloff? Which catalysts matter most?

Global equities: Rally or selloff? Which catalysts matter most?

STREETINSIDER.COMOct 20, 12:37 PM UTC
1 / 2
0

ByteDance, Alibaba, and Tencent have placed orders for over 3 million Nvidia RTX PRO 5500 chips, totaling more than $35 billion. Nvidia (NVDA) has informed customers it cannot guarantee fulfilling these orders, citing demand exceeding production capacity and U.S. export restrictions .

Key points:

  • Chinese tech giants ordered more than double the 3 million RTX PRO 5500 cards Nvidia can produce globally in 2027.
  • Nvidia warned partners they might receive only 5-10% of requested quantities.
  • The RTX PRO 5500 is among the most powerful chips available to China under current U.S. controls, as advanced Blackwell and Hopper chips are restricted .

This highlights intense AI chip demand from China despite export curbs, signaling continued supply constraints for advanced AI hardware.

ByteDance, Alibaba and Tencent order $35 billion of Nvidia chips: Reuters

ByteDance, Alibaba and Tencent order $35 billion of Nvidia chips: Reuters

INVESTING.COMOct 20, 9:23 AM UTC
0

Investors are increasingly hedging against AI-related debt, driving a surge in Credit Default Swaps (CDS) for major tech firms. Weekly trading volumes for CDS linked to Oracle, SpaceX, Alphabet, Amazon, Meta, Broadcom, and Nvidia jumped from under $2 billion in July to over $9 billion in September .

Key points:

  • AI-linked debt issuance reached $466 billion in 2026, up from $101 billion in 2025 .
  • Cost of CDS for AI-linked companies like CoreWeave and Microsoft hit record highs .
  • Five-year Meta CDS climbed to 108 bps, Nvidia to 101 bps, both record highs .
  • Oracle's CDS rose to 322 bps from 144 bps YTD; SpaceX hit 226 bps .
  • HSBC CEO warns investors to be selective in data center investments, citing potential challenges in tenancy agreements and pricing .

This trend signals growing caution around the sustainability and financial risks associated with the rapid expansion of AI infrastructure, despite a recent rebound in US tech stocks .

Investors hedge AI boom with credit default swaps on tech debt

Investors hedge AI boom with credit default swaps on tech debt

STREETINSIDER.COMOct 20, 8:23 AM UTC
HSBC CEO warns the AI boom won’t make every data center a good bet

HSBC CEO warns the AI boom won’t make every data center a good bet

CNBC.COMOct 20, 10:39 AM UTC
CNBC Daily Open: Tech rebounds in the U.S., but Asia isn’t buying it yet

CNBC Daily Open: Tech rebounds in the U.S., but Asia isn’t buying it yet

CNBC.COMOct 20, 7:14 AM UTC
European chip stocks fall, tracking Asian selloff over AI investment worries

European chip stocks fall, tracking Asian selloff over AI investment worries

INVESTING.COMOct 20, 7:35 AM UTC
1 / 4
0

Tech stocks, particularly in the AI sector, saw a rebound with the Nasdaq Composite rallying over 1% after last week's rout . However, analysts warn it's too soon to be aggressively bullish due to technical and fundamental headwinds . Concerns about AI infrastructure debt and potential credit stress for companies like Oracle continue to loom. Former Google CEO Eric Schmidt's significant stake in Anthropic highlights the high valuations in the private AI space, with Anthropic's IPO potentially at a $1.5 trillion valuation . Investors are advised to wait for clearer signals before re-entering the sector .

CNBC Daily Open: Tech investors buy the dip — but debt remains a concern

CNBC Daily Open: Tech investors buy the dip — but debt remains a concern

CNBC.COMOct 20, 1:13 AM UTC
Jim Cramer says don’t chase the AI rebound just yet. Here’s what needs to happen first

Jim Cramer says don’t chase the AI rebound just yet. Here’s what needs to happen first

CNBC.COMOct 19, 10:46 PM UTC
Former Google CEO Schmidt owns 1% stake in Anthropic, Bloomberg reports

Former Google CEO Schmidt owns 1% stake in Anthropic, Bloomberg reports

INVESTING.COMOct 19, 10:24 PM UTC
1 / 3
0

Crown Holdings Inc. (NYSE: CCK) shares fell 5.9% after the packaging manufacturer reported Q3 adjusted EPS of $2.39 and revenue of $3.71 billion, both exceeding analyst expectations. However, the company's Q4 adjusted EPS guidance of $1.63-$1.73, with a midpoint of $1.68, fell short of the $1.79 consensus. Robust global beverage can volumes, up 6%, helped offset rising input costs .

Crown Holdings falls 5% on weak Q4 guidance despite Q3 beat

Crown Holdings falls 5% on weak Q4 guidance despite Q3 beat

STREETINSIDER.COMOct 19, 8:19 PM UTC
2

Concerns are mounting over the financial health of AI infrastructure providers. S&P Global warns that top hyperscalers likely have more AI-linked debt than currently known, citing 'interconnected financing structures' and projecting negative free cash flow for major players until at least next year .

This comes as CoreWeave, a key AI cloud provider, sees its unsecured bonds yield ~15% and 5-year credit default swaps trade above 1100 basis points, impacting partners like Galaxy Digital . Meanwhile, Nscale is in talks for a massive $45 billion computing deal with Anthropic, but investors are scrutinizing the economics of such debt-funded expansions .

Top hyperscalers likely to have more AI-linked debt than now known, S&P Global warns

Top hyperscalers likely to have more AI-linked debt than now known, S&P Global warns

INVESTING.COMOct 19, 4:18 PM UTC
StoneX reiterates Galaxy Digital stock rating on tenant concerns

StoneX reiterates Galaxy Digital stock rating on tenant concerns

INVESTING.COMOct 19, 2:50 PM UTC
Nscale in talks for $45 billion Anthropic AI deal as IPO looms

Nscale in talks for $45 billion Anthropic AI deal as IPO looms

STREETINSIDER.COMOct 19, 7:46 PM UTC
1 / 3
1

The biotech sector is experiencing significant volatility following key clinical trial readouts:

  • Disc Medicine (IRON) surged 60% after its Phase 3 APOLLO trial for erythropoietic protoporphyria (EPP) met all primary and secondary endpoints .
  • Veradermics (MANE) rose 6.7% premarket as its oral hair loss drug VDPHL01 met all Phase 3 goals .
  • Conversely, EyePoint (EYPT) plummeted 86% after its Phase 3 wet AMD study missed its primary endpoint, leading Jefferies to downgrade the stock to Hold with a reduced price target .

These results highlight the high-stakes nature of clinical development and its immediate impact on biotech valuations.

Disc Medicine surge 60% on positive Phase 3 trial for rare sunlight disorder

Disc Medicine surge 60% on positive Phase 3 trial for rare sunlight disorder

STREETINSIDER.COMOct 19, 11:53 AM UTC
Veradermics stock surges as hair loss drug meets Phase 3 goals

Veradermics stock surges as hair loss drug meets Phase 3 goals

STREETINSIDER.COMOct 19, 1:24 PM UTC
Jefferies downgrades Eyepoint stock rating on trial miss

Jefferies downgrades Eyepoint stock rating on trial miss

INVESTING.COMOct 19, 2:50 PM UTC
1 / 3
2

Disc Medicine (NASDAQ: IRON) shares surged 60% premarket after its Phase 3 APOLLO trial for bitopertin, an investigational treatment for erythropoietic protoporphyria (EPP), met all primary and secondary endpoints .

Key highlights:

  • Reduced Toxic Buildup: 41.4% reduction in whole-blood metal-free protoporphyrin IX.
  • Increased Light Exposure: Patients gained 12.2 hours of pain-free light exposure monthly.
  • Improved Safety: Generally well-tolerated with mild/moderate dizziness as the most common side effect.

The company plans to resubmit a New Drug Application (NDA) to the FDA by end of 2026, with a regulatory decision anticipated by mid-2027 .

Disc Medicine surge 60% on positive Phase 3 trial for rare sunlight disorder

Disc Medicine surge 60% on positive Phase 3 trial for rare sunlight disorder

STREETINSIDER.COMOct 19, 11:53 AM UTC
2

Social unrest and political instability in France are impacting European assets. The CAC 40 index is down nearly 1%, and the French 10-year bond yield jumped 7 basis points, nearing multi-decade highs. The euro also fell 0.15% against the dollar . Concerns about France's fiscal outlook and the widening 'OAT-Bund spread' are raising fears of higher borrowing costs and tighter regulation, with French yields now surpassing Italy or Greece .

French unrest compounds debt crisis fears. Paris-listed stocks, bonds and the euro fall

French unrest compounds debt crisis fears. Paris-listed stocks, bonds and the euro fall

CNBC.COMOct 19, 9:07 AM UTC
France concerns weigh on Europe, while Wall Street looks to AI earnings

France concerns weigh on Europe, while Wall Street looks to AI earnings

INVESTING.COMOct 19, 9:30 AM UTC
1 / 2
2